ArticleFrontiers in endocrinology2022

Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study.

Tianci Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.